The Immunobiology of Receptor Activator for Nuclear Factor Kappa B Ligand and Myeloid‐Derived Suppressor Cell Activation in Immunoglobulin G4–Related Sclerosing Cholangitis-Reference-Cited by-同舟云学术

The Immunobiology of Receptor Activator for Nuclear Factor Kappa B Ligand and Myeloid‐Derived Suppressor Cell Activation in Immunoglobulin G4–Related Sclerosing Cholangitis

Published:2018-10-09 Issue:5 Volume:68 Page:1922-1936
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lian Min¹,Wang Qixia¹,Jiang Xiang¹,Zhang Jun¹,Wei Yiran¹,Li Yanmei¹,Li Bo¹,Chen Weihua¹,Zhang Haiyan¹,Miao Qi¹,Peng Yanshen¹,Xiao Xiao¹,Sheng Li¹,Zhang Weici²,Fang Jingyuan¹,Tang Ruqi¹,Gershwin M. Eric²,Ma Xiong¹

Affiliation:

1. Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health; State Key Laboratory for Oncogenes and Related Genes, Renji Hospital; School of MedicineShanghai Jiao Tong University; and Shanghai Institute of Digestive Disease Shanghai China

2. Division of Rheumatology, Allergy and Clinical Immunology, Department of Internal MedicineUniversity of California at Davis Davis CA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30095

Reference48 articles.

1. Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC/AIH and PSC alone

2. Immunology of IgG4-related disease